Olema Pharmaceuticals, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -25.0% | -25.0% | -24.0% |
| FY2022 | -53.0% | -53.0% | -48.6% |
| FY2023 | -38.1% | -38.1% | -34.9% |
| FY2024 | -31.7% | -31.7% | -28.7% |
| FY2025 | -33.9% | -33.9% | -30.5% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -25.0% | -25.0% | -24.0% |
| FY2022 | -53.0% | -53.0% | -48.6% |
| FY2023 | -38.1% | -38.1% | -34.9% |
| FY2024 | -31.7% | -31.7% | -28.7% |
| FY2025 | -33.9% | -33.9% | -30.5% |